Earnings Feed
Start Free
REGENERON PHARMACEUTICALS INC·4

Jun 7, 4:14 PM ET

KOLINSKI STUART 4

4 · REGENERON PHARMACEUTICALS INC · Filed Jun 7, 2010

Insider Transaction Report

Form 4
Period: 2010-06-03
REGENERON PHARMACEUTICALS INCREGN
KOLINSKI STUART
SVP General Counsel and Secret
Transactions
  • Tax Payment

    Common Stock

    2010-06-03$30.02/sh−3,539$106,241→ 19,574 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2010-06-03−12,500→ 0 total
    Exercise: $8.50Exp: 2011-12-18→ Common Stock (12,500 underlying)
  • Exercise/Conversion

    Common Stock

    2010-06-03$8.50/sh+12,500$106,250→ 23,113 total
  • Tax Payment

    Common Stock

    2010-06-03$30.02/sh−3,245$97,415→ 16,329 total
Holdings

  • Common Stock

    (indirect: By 401(k))
    3,710
Footnotes (3)
  • [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  • [F2]The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
  • [F3]Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT